dipropizine has been researched along with Alveolitis, Fibrosing in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Levodropropizine dosage was 60 mg t." | 1.28 | [Efficacy and safety of the use of levodropropizine in patients with chronic interstitial lung diseases]. ( Gunella, G; Massimo Vanasia, CB; Zanasi, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunella, G | 1 |
| Zanasi, A | 1 |
| Massimo Vanasia, CB | 1 |
1 other study available for dipropizine and Alveolitis, Fibrosing
| Article | Year |
|---|---|
[Efficacy and safety of the use of levodropropizine in patients with chronic interstitial lung diseases].
Topics: Adult; Aged; Aged, 80 and over; Antitussive Agents; Drug Evaluation; Drug Tolerance; Female; Humans; | 1991 |